Vivos Therapeutics, Inc. - VVOS Net Assets per Single Share

Graphic logo of Vivos Therapeutics, Inc (VVOS)

Vivos Therapeutics (VVOS) develops dental systems to combat apnea in US laboratories, yet its device assembly plants are operating strictly according to plan. The expected book value per share on the consolidated chart at GURU.Markets resolves this contradiction, with the indicator currently at -0.34. Strict FDA regulations and unique patents ensure business stability, creating significant barriers to entry for new players.

Vivos Therapeutics, Inc - VVOS Net Assets per Share (period 07/04/2022 - 10/28/2026)

Summary analytical data breakdowns for vivoslife.com (VVOS)

- price and consensus price forecast:
Price Chart Vivos Therapeutics, Inc|VVOS - Average Forecast Price
- market capitalization data:
Market Value Vivos Therapeutics, Inc.|VVOS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Vivos Therapeutics|VVOS - Book Valuation of Business|Market Value to Book Value Ratio vivoslife.com|VVOS - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Vivos Therapeutics|VVOS - Long-Term Liabilities to Capital|Short-Term Debt to Capital Vivos Therapeutics, Inc.|VVOS - Company Total Debt|Debts to Book Capitalization Vivos Therapeutics, Inc.
Analysis of all company metrics:Vivos Therapeutics, Inc VVOS
Finished products of vivoslife.com

To isolate fundamental stability from market noise, it is essential to analyze the difference between total assets and liabilities distributed across the number of shares. The trend in the net book value per share reflects real capital accumulation, which is critical for Vivos Therapeutics (VVOS) amid geopolitical risks and the complexities of medical equipment certification in closed foreign markets.

Competitors of Vivos Therapeutics (VVOS)

BSX (Boston Scientific Inc) - Net Assets per Single Share|EW: Net Asset Value per Share|ResMed Inc. - Net Assets per Single Share|PODD (insulet.com) - Net Assets per Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share AXGN|SIBN - Net Assets per Share|Accounting Value per Share Orthofix Medical Inc.|BVS - Share Book Value|Book Value per Share KIDS|Treace Medical Concepts Inc (TMCI) - Net Asset Value per Share|Book Value per Share Strata Critical Medical Corp (SRTA)|Equity per Share Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Accounting Value per Share|Accounting Value of a Share CLPT (clearpointneuro.com)|Stereotaxis - Net Assets per Single Share|Accounting Value per Share Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Value per Share|OBIO - Net Asset Value per Share|Book Value per Share anikatherapeutics.com|inspiremd.com (NSPR) - Equity per Share|ZJYL: Book Value per Share|Net Assets per Share Vivani|Book Value per Share XTNT (Xtant Medical Holdings)|Accounting Value per Share NeuroOne Medical Technologies Corp. (NMTC)|Book Value per Share MODD (Modular Medical, Inc.)|myomo.com - Book Value per Share|COCH - Net Assets per Single Share|enVVeno Medical Corporation (NVNO) - Net Assets per Single Share|Accounting Value per Share sintx.com SINT|Tenon Medical Inc (TNON) - Accounting Value of a Share|Book Value per Share LFWD (ReWalk Robotics Ltd.)|Net Asset Value per Share AMIX|IVF: Net Assets per Single Share|Book Value of One Share Bone Biologics Corp. BBLG|Accounting Value per Share AXNX (Axonics Modulation Technologies)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)